Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

Abstract: This invention provides a luminescent composition comprising a polymer and at least one phosphorescent compound, characterized in that the electronic conjunction chain coefficient Ze of the main repeating minimum unit of the polymer falls within the following range: 0<Ze?2.00 (1) wherein the electronic conjunction chain coefficient Ze is defined as a slope obtained by linear approximation of function Tm=Tm (1/ne) by the least square method wherein ne represents the number of conjugated electrons contained in repeating minimum units; and Tm represents, for m-mer obtained by bonding repeating minimum units, the lowest triplet excitation energy in each m-mer when the number m is varied from 1 to 3 by one by one. Here in the number of conjugated electrons, only the conjugated electrons present in the main chain of the repeating minimum units are taken into consideration, provided that, when there are a plurality of main repeating minimum units, the minimum Ze is used.

Abstract: In order to prevent a signal which a terminal station does not require from being intercepted by the terminal station without greatly changing the power of optical signals to be transmitted from a node to the terminal station, a node device is provided with: a first optical unit which outputs a first optical signal received from a first terminal station and addressed to a second terminal station, and a second optical signal received from the first terminal station, addressed to a third terminal station, and having a different wavelength band from the first optical signal; and a second optical unit to which the first and second optical signals outputted from the first optical unit are inputted, and which shifts the frequency of the first optical signal by a predetermined amount to create a fourth optical signal, passes the second optical signal without any change, couples the second and fourth optical signals, and transmits a resultant signal to the third terminal station.

Abstract: A polymer compound is provided having constitutional units of formula (1) and formula (2), and a constitutional unit of formula (3) and/or (4?): wherein Ar1 to Ar4, Ar20, Ar30? and Ar40 represent arylene groups or the like; Ar5 to Ar7 represent aryl groups or the like; Ar8 represents (2+p)-valent aromatic hydrocarbon group or the like; Ar10 represents (2+n)-valent aromatic hydrocarbon group or the like; R1 represents alkyl group or the like; La, Lb, Lg and Lh represent alkylene groups or the like; LA and LD represent oxygen atoms or the like; Q1 represents monovalent crosslinkable group; Q2? to Q4? represent monovalent crosslinkable groups or the like; x, y, c, nA and nD represent 0 or 1; p represents integer of 1 or greater; na and ng represent integer of 0 to 3; nb and nh represent integer of 0 to 12; and n represents integer of 1 to 4.

Abstract: Provided is a surface-treated steel sheet with a compound layer containing F and composed essentially or Zr at least on one surface thereof, wherein the Zr amount is 80 to 350 mg/m2 and the F amount is 0.5 to 10 mg/m2 within the layer, and an organic resin coated metal container manufactured using the surface-treated steel sheet. The surface-treated steel sheet of the present invention is manufactured through forming a layer having the Zr amount of 80 to 350 mg/m2 at least on one surface of a steel sheet by cathode electrolytic treatment in an aqueous solution containing a Zr ion and F ion, and subsequently adjusting the surface to control the F amount to 0.5 to 10 mg/m2 by one or more treatments selected from immersion and spraying with an ion-containing aqueous solution and cathode electrolytic treatment in the ion-containing aqueous solution.

Abstract: In order to prevent a signal which a terminal station does not require from being intercepted by the terminal station without greatly changing the power of optical signals to be transmitted from a node to the terminal station, a node device is provided with: a first optical unit which outputs a first optical signal received from a first terminal station and addressed to a second terminal station, and a second optical signal received from the first terminal station, addressed to a third terminal station, and having a different wavelength band from the first optical signal; and a second optical unit to which the first and second optical signals outputted from the first optical unit are inputted, and which shifts the frequency of the first optical signal by a predetermined amount to create a fourth optical signal, passes the second optical signal without any change, couples the second and fourth optical signals, and transmits a resultant signal to the third terminal station.

Abstract: The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

Abstract: The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

Abstract: Provided is a compound having an AMPA receptor function enhancing action, and useful as a prophylactic or therapeutic drug for depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. A compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.

Abstract: The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

Abstract: The problem of the present invention is to provide a compound having a PDE2A inhibitory action, and useful as a prophylactic or therapeutic drug for schizophrenia, Alzheimer's disease and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.

Abstract: Provided is a surface-treated steel sheet with a compound layer containing F and composed essentially or Zr at least on one surface thereof, wherein the Zr amount is 80 to 350 mg/m2 and the F amount is 0.5 to 10 mg/m2 within the layer, and an organic resin coated metal container manufactured using the surface-treated steel sheet. The surface-treated steel sheet of the present invention is manufactured through forming a layer having the Zr amount of 80 to 350 mg/m2 at least on one surface of a steel sheet by cathode electrolytic treatment in an aqueous solution containing a Zr ion and F ion, and subsequently adjusting the surface to control the F amount to 0.5 to 10 mg/m2 by one or more treatments selected from immersion and spraying with an ion-containing aqueous solution and cathode electrolytic treatment in the ion-containing aqueous solution.

Abstract: This invention provides a luminescent composition comprising a polymer and at least one phosphorescent compound, characterized in that the electronic conjunction chain coefficient Ze of the main repeating minimum unit of the polymer falls within the following range: 0<Ze?2.00 (1) wherein the electronic conjunction chain coefficient Ze is defined as a slope obtained by linear approximation of function Tm=Tm (1/ne) by the least square method wherein ne represents the number of conjugated electrons contained in repeating minimum units; and Tm represents, for m-mer obtained by bonding repeating minimum units, the lowest triplet excitation energy in each m-mer when the number m is varied from 1 to 3 by one by one. Here in the number of conjugated electrons, only the conjugated electrons present in the main chain of the repeating minimum units are taken into consideration, provided that, when there are a plurality of main repeating minimum units, the minimum Ze is used.

Abstract: A compound represented by the formula (I): wherein each symbol is as described in the SPECIFICATION, or a salt thereof has a PDE2A inhibitory action, and is useful as a prophylactic or therapeutic drug for schizophrenia, Alzheimer's disease and the like.

Abstract: This invention provides a luminescent composition comprising a polymer and at least one phosphorescent compound, characterized in that the electronic conjunction chain coefficient Ze of the main repeating minimum unit of the polymer falls within the following range: 0<Ze?2.00 (1) wherein the electronic conjunction chain coefficient Ze is defined as a slope obtained by linear approximation of function Tm=Tm(1/ne) by the least square method wherein ne represents the number of conjugated electrons contained in repeating minimum units; and Tm represents, for m-mer obtained by bonding repeating minimum units, the lowest triplet excitation energy in each m-mer when the number m is varied from 1 to 3 by one by one. Here in the number of conjugated electrons, only the conjugated electrons present in the main chain of the repeating minimum units are taken into consideration, provided that, when there are a plurality of main repeating minimum units, the minimum Ze is used.

Abstract: The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

Abstract: A polymer compound is provided having constitutional units of formula (1) and formula (2), and a constitutional unit of formula (3) and/or (4?): wherein Ar1 to Ar4, Ar20, Ar30? and Ar40 represent arylene groups or the like; Ar5 to Ar7 represent aryl groups or the like; Ar8 represents (2+p)-valent aromatic hydrocarbon group or the like; Ar10 represents (2+n)-valent aromatic hydrocarbon group or the like; R1 represents alkyl group or the like; La, Lb, Lg and Lh represent alkylene groups or the like; LA and LD represent oxygen atoms or the like; Q1 represents monovalent crosslinkable group; Q2? to Q4? represent monovalent crosslinkable groups or the like; x, y, c, nA and nD represent 0 or 1; p represents integer of 1 or greater.; na and ng represent integer of 0 to 3; nb and nh represent integer of 0 to 12; and n represents integer of 1 to 4.

Abstract: The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

Abstract: There is provided a reception quality measurement method that measures reception quality of a measurement target cell with a mobile terminal apparatus. The method includes performing reception quality measurements in a certain bandwidth with respect to each of a plurality of frequencies in a frequency band of the measurement target cell when the frequency band of the measurement target cell and a frequency band of a neighboring cell overlap with each other, and averaging results of the reception quality measurements at the plurality of frequencies to obtain an averaged value as the reception quality of the measurement target cell.